Researchers say ability to see for the first time previously hidden indicators of MS disease progression is an important advance.

Researchers have developed new AI approach to select chemical compounds potentially effective for treating tuburculosis.

PROTACs have helped redefine what may be possible in drug discovery. By harnessing the ubiquitin-proteasome system to ...

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.

Less than a month after its stock roller-coastered on safety signals associated with its late-stage ulcerative colitis (UC) ...

This eBook explores how researchers can move beyond correlation and towards mechanism in microbiome research—from preserving physiologically relevant microbial communities to directly measuring ...

As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...

Synthetic organizers provide a way to control formation of kidney organoids as more reliable models for studying disease and ...

The work with Nvidia also focuses on the agentic guardrails required for the responsible and reliable deployment of AI in lab ...

Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...

Pierre-Alain Ruffieux, Cytiva’s group executive, bioprocess, discusses completion of the doubling of the company’s liquid ...